Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The emerging role of exercise and health counseling in patients with acute leukemia undergoing chemotherapy during outpatient management

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{6a5b8e1d09a64e1483630ff75f43c6e0,
title = "The emerging role of exercise and health counseling in patients with acute leukemia undergoing chemotherapy during outpatient management",
abstract = "This study investigates the feasibility, safety and benefits of a 6-week exercise and health counseling intervention in patients with acute leukemia undergoing consolidation chemotherapy during outpatient management. Seventeen of twenty patients completed study requirements (85{\%}), adherence to exercise was 73{\%} and for health counseling 92{\%}. There were improvements in the 6-min-walk-distance (p=0.0013), sit-to-stand test (p=0.0062), the right and left biceps arm-curl tests p=0.0002 and p=0.0002, respectively; health-related quality of life (p=0.0209) (FACT-An), vitality (p=0.0015), mental health (p=0.0471) and physical component scale (p=0.0295) (SF36). Significant reduction in the symptom burden (p=0.0021) and symptom interference on daily life activities (p=0.0069) (MDASI). No adverse reactions were observed.",
author = "Mary Jarden and Lis Adamsen and Lars Kjeldsen and Henrik Birgens and Anders Tolver and Christensen, {Jesper Frank} and Merete Stensen and Vivi-Ann S{\o}rensen and Tom M{\o}ller",
note = "Copyright {\circledC} 2012 Elsevier Ltd. All rights reserved.",
year = "2013",
doi = "10.1016/j.leukres.2012.09.001",
language = "English",
volume = "37",
pages = "155--61",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Pergamon",
number = "2",

}

RIS

TY - JOUR

T1 - The emerging role of exercise and health counseling in patients with acute leukemia undergoing chemotherapy during outpatient management

AU - Jarden, Mary

AU - Adamsen, Lis

AU - Kjeldsen, Lars

AU - Birgens, Henrik

AU - Tolver, Anders

AU - Christensen, Jesper Frank

AU - Stensen, Merete

AU - Sørensen, Vivi-Ann

AU - Møller, Tom

N1 - Copyright © 2012 Elsevier Ltd. All rights reserved.

PY - 2013

Y1 - 2013

N2 - This study investigates the feasibility, safety and benefits of a 6-week exercise and health counseling intervention in patients with acute leukemia undergoing consolidation chemotherapy during outpatient management. Seventeen of twenty patients completed study requirements (85%), adherence to exercise was 73% and for health counseling 92%. There were improvements in the 6-min-walk-distance (p=0.0013), sit-to-stand test (p=0.0062), the right and left biceps arm-curl tests p=0.0002 and p=0.0002, respectively; health-related quality of life (p=0.0209) (FACT-An), vitality (p=0.0015), mental health (p=0.0471) and physical component scale (p=0.0295) (SF36). Significant reduction in the symptom burden (p=0.0021) and symptom interference on daily life activities (p=0.0069) (MDASI). No adverse reactions were observed.

AB - This study investigates the feasibility, safety and benefits of a 6-week exercise and health counseling intervention in patients with acute leukemia undergoing consolidation chemotherapy during outpatient management. Seventeen of twenty patients completed study requirements (85%), adherence to exercise was 73% and for health counseling 92%. There were improvements in the 6-min-walk-distance (p=0.0013), sit-to-stand test (p=0.0062), the right and left biceps arm-curl tests p=0.0002 and p=0.0002, respectively; health-related quality of life (p=0.0209) (FACT-An), vitality (p=0.0015), mental health (p=0.0471) and physical component scale (p=0.0295) (SF36). Significant reduction in the symptom burden (p=0.0021) and symptom interference on daily life activities (p=0.0069) (MDASI). No adverse reactions were observed.

U2 - 10.1016/j.leukres.2012.09.001

DO - 10.1016/j.leukres.2012.09.001

M3 - Journal article

VL - 37

SP - 155

EP - 161

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 2

ER -

ID: 36544329